NO794069L - Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater. - Google Patents
Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.Info
- Publication number
- NO794069L NO794069L NO794069A NO794069A NO794069L NO 794069 L NO794069 L NO 794069L NO 794069 A NO794069 A NO 794069A NO 794069 A NO794069 A NO 794069A NO 794069 L NO794069 L NO 794069L
- Authority
- NO
- Norway
- Prior art keywords
- imidayold
- derivatives
- procedure
- preparation
- therapeutically effective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7848367 | 1978-12-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO794069L true NO794069L (no) | 1980-06-16 |
| NO153135B NO153135B (no) | 1985-10-14 |
| NO153135C NO153135C (no) | 1986-01-22 |
Family
ID=10501705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO794069A NO153135C (no) | 1978-12-13 | 1979-12-12 | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-(fenoksyalkyl)-imidazolderivater. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US4602016A (no) |
| JP (1) | JPS585197B2 (no) |
| KR (1) | KR830001243B1 (no) |
| AR (1) | AR227637A1 (no) |
| AT (1) | AT373879B (no) |
| AU (1) | AU517892B2 (no) |
| BE (1) | BE880584A (no) |
| CA (1) | CA1108137A (no) |
| CH (1) | CH644597A5 (no) |
| CS (1) | CS216517B2 (no) |
| DD (1) | DD147943A5 (no) |
| DE (1) | DE2950019A1 (no) |
| DK (1) | DK471479A (no) |
| EG (1) | EG14227A (no) |
| ES (1) | ES8101556A1 (no) |
| FI (1) | FI70888C (no) |
| FR (1) | FR2444031A1 (no) |
| GB (1) | GB2038821B (no) |
| GR (1) | GR73003B (no) |
| HU (1) | HU183016B (no) |
| IE (1) | IE49318B1 (no) |
| IL (1) | IL58917A (no) |
| IT (1) | IT1194900B (no) |
| LU (1) | LU81985A1 (no) |
| NL (1) | NL177749C (no) |
| NO (1) | NO153135C (no) |
| NZ (1) | NZ192360A (no) |
| PH (1) | PH15056A (no) |
| PL (1) | PL134005B1 (no) |
| PT (1) | PT70571A (no) |
| SE (1) | SE444937B (no) |
| SU (1) | SU878195A3 (no) |
| YU (1) | YU301879A (no) |
| ZA (1) | ZA796708B (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4350696A (en) * | 1980-03-08 | 1982-09-21 | Pfizer Inc. | Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof |
| US4444775A (en) * | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| DE3148291A1 (de) * | 1981-12-05 | 1983-06-09 | Basf Ag, 6700 Ludwigshafen | Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| JPS58113178A (ja) * | 1981-12-28 | 1983-07-05 | Yamanouchi Pharmaceut Co Ltd | 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体 |
| US4470986A (en) * | 1982-12-21 | 1984-09-11 | Ciba-Geigy Corporation | Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors |
| US4588732A (en) * | 1982-12-21 | 1986-05-13 | Ciba-Geigy Corporation | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors |
| NL8301550A (nl) * | 1983-05-03 | 1984-12-03 | Gist Brocades Nv | Imidazolethanol esters. |
| US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| IT1212791B (it) * | 1983-11-24 | 1989-11-30 | Medea Res Srl | Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono. |
| ES539074A0 (es) * | 1984-12-10 | 1985-11-16 | Ferrer Int | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. |
| US4894385A (en) * | 1985-01-16 | 1990-01-16 | Sankyo Company Limited | Imidazole derivatives as inhibitors of TXA2 synthesis |
| KR920002129B1 (ko) | 1986-01-27 | 1992-03-12 | 상꾜 가부시끼가이샤 | 티아나프텐 유도체의 제조방법 |
| EP0239306B1 (en) | 1986-03-27 | 1993-06-02 | Merck Frosst Canada Inc. | Tetrahydrocarbazole esters |
| JPS63179840A (ja) * | 1986-07-24 | 1988-07-23 | Yamanouchi Pharmaceut Co Ltd | 新規化学物質 |
| ES2018860B3 (es) * | 1987-04-03 | 1991-05-16 | Cl Pharma | Nuevos derivados de 2 - acido acetico de tieniloxido, un procedimiento para su preparacion y el contenido en preparados farmaceuticos |
| JPH01125372A (ja) * | 1988-09-12 | 1989-05-17 | Yamanouchi Pharmaceut Co Ltd | イミダゾリルアルキルオキシベンゼン誘導体 |
| DE4204686A1 (de) * | 1992-02-17 | 1993-08-19 | Gruenenthal Gmbh | Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln |
| ES2201104T3 (es) * | 1994-04-26 | 2004-03-16 | Roche Palo Alto Llc | Derivados de benzociclohexilimidazoltiona. |
| WO1999045905A2 (en) * | 1998-03-13 | 1999-09-16 | Pozen Inc. | Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists |
| ES2172436B1 (es) | 2000-10-31 | 2004-01-16 | Almirall Prodesfarma Sa | Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos. |
| AU2003244913A1 (en) * | 2002-07-09 | 2004-01-23 | B.M.R.A. Corporation B.V. | Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor |
| US20050059741A1 (en) * | 2003-08-07 | 2005-03-17 | B.M.R.A. Corporation B.V. | Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1 |
| KR101275814B1 (ko) * | 2006-06-23 | 2013-06-18 | 삼성에스디아이 주식회사 | 분산제 화합물 및 그의 제조방법 |
| CA2708281A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| CN101811974B (zh) * | 2010-04-15 | 2012-12-12 | 合肥医工医药有限公司 | 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途 |
| CN101851209B (zh) * | 2010-06-21 | 2012-09-19 | 合肥医工医药有限公司 | 咪唑乙基香草酸醚、其制备方法及其医药用途 |
| CN104718188B (zh) * | 2012-05-22 | 2018-08-21 | 基因泰克公司 | N-取代的苯甲酰胺类及其在治疗疼痛中的用途 |
| US9388179B2 (en) | 2012-10-26 | 2016-07-12 | Merck Sharp & Dohme Corp. | N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels |
| WO2023240378A1 (zh) * | 2022-06-13 | 2023-12-21 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
| CN114736161B (zh) * | 2022-06-13 | 2022-09-13 | 南京医工医药技术有限公司 | 咪唑烷基香草酸醚衍生物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3534061A (en) * | 1967-12-04 | 1970-10-13 | Parke Davis & Co | N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles |
| US4085209A (en) * | 1975-02-05 | 1978-04-18 | Rohm And Haas Company | Preparation and safening effect of 1-substituted imidazole metal salt complexes |
| US4078071A (en) * | 1976-03-08 | 1978-03-07 | Syntex (U.S.A.) Inc. | Derivatives of substituted N-alkyl imidazoles |
| JPS5951943B2 (ja) * | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
-
1979
- 1979-11-07 DK DK471479A patent/DK471479A/da not_active Application Discontinuation
- 1979-11-19 US US06/095,755 patent/US4602016A/en not_active Expired - Lifetime
- 1979-12-10 GB GB7942535A patent/GB2038821B/en not_active Expired
- 1979-12-10 AR AR279215A patent/AR227637A1/es active
- 1979-12-11 YU YU03018/79A patent/YU301879A/xx unknown
- 1979-12-11 NZ NZ192360A patent/NZ192360A/xx unknown
- 1979-12-11 FI FI793868A patent/FI70888C/fi not_active IP Right Cessation
- 1979-12-11 ZA ZA00796708A patent/ZA796708B/xx unknown
- 1979-12-11 IL IL58917A patent/IL58917A/xx unknown
- 1979-12-11 PT PT70571A patent/PT70571A/pt unknown
- 1979-12-11 SE SE7910204A patent/SE444937B/sv unknown
- 1979-12-11 ES ES486782A patent/ES8101556A1/es not_active Expired
- 1979-12-11 GR GR60727A patent/GR73003B/el unknown
- 1979-12-11 IT IT41669/79A patent/IT1194900B/it active
- 1979-12-11 NL NLAANVRAGE7908899,A patent/NL177749C/xx not_active IP Right Cessation
- 1979-12-11 HU HU79PI699A patent/HU183016B/hu unknown
- 1979-12-12 SU SU792854456A patent/SU878195A3/ru active
- 1979-12-12 BE BE0/198542A patent/BE880584A/fr not_active IP Right Cessation
- 1979-12-12 AT AT0783379A patent/AT373879B/de not_active IP Right Cessation
- 1979-12-12 LU LU81985A patent/LU81985A1/fr unknown
- 1979-12-12 DE DE19792950019 patent/DE2950019A1/de not_active Ceased
- 1979-12-12 NO NO794069A patent/NO153135C/no unknown
- 1979-12-12 JP JP54161382A patent/JPS585197B2/ja not_active Expired
- 1979-12-12 KR KR1019790004397A patent/KR830001243B1/ko not_active Expired
- 1979-12-12 CA CA341,691A patent/CA1108137A/en not_active Expired
- 1979-12-12 PL PL1979220351A patent/PL134005B1/pl unknown
- 1979-12-12 AU AU53725/79A patent/AU517892B2/en not_active Ceased
- 1979-12-12 IE IE2403/79A patent/IE49318B1/en unknown
- 1979-12-12 FR FR7930438A patent/FR2444031A1/fr active Granted
- 1979-12-12 EG EG743/79A patent/EG14227A/xx active
- 1979-12-12 CS CS798708A patent/CS216517B2/cs unknown
- 1979-12-13 DD DD79217645A patent/DD147943A5/de unknown
- 1979-12-13 CH CH1106279A patent/CH644597A5/de not_active IP Right Cessation
- 1979-12-13 PH PH23412A patent/PH15056A/en unknown
-
1985
- 1985-03-21 US US06/714,422 patent/US4636500A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO794069L (no) | Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater. | |
| NO151588C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater | |
| NO792787L (no) | Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler | |
| NO790257L (no) | Fremgangsmaate ved fremstilling av 9-desoksy-9a-metylen-isostere av pgi2 | |
| NO801155L (no) | Fremgangsmaate ved fremstilling av acyl-carnitinamider | |
| NO790358L (no) | Fremgangsmaate for fremstilling av alkylendiaminderivater | |
| NO154058C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer. | |
| NO158540C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser. | |
| NO802913L (no) | Fremgangsmaate ved fremstilling av cephalosporinforbindelse | |
| NO791831L (no) | Fremgangsmaate for fremstilling av aminotiazoler | |
| NO154522C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. | |
| NO792404L (no) | Fremgangsmaate for fremstilling av imidazolderivater | |
| NO151201C (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater | |
| NO150155C (no) | Fremgangsmaate for fremstilling av 2-pyrrolidon-forbindelser | |
| NO152255C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO791139L (no) | Fremgangsmaate for fremstilling av lysergolderivater | |
| NO152787C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner. | |
| NO153853C (no) | Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner. | |
| NO155539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater. | |
| NO152840C (no) | Fremgangsmaate for fremstilling av dibenzyletere. | |
| NO147310C (no) | Fremgangsmaate for fremstilling av substituerte antitumorantracykliner | |
| NO791220L (no) | Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner | |
| NO790328L (no) | Fremgangsmaate ved fremstilling av derivater av nafthyl-1-eddiksyre. | |
| NO153730C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 10-brom-e-homo-eburnan. |